Capricor Therapeutics (CAPR) Institutional Ownership $18.60 -0.86 (-4.42%) (As of 11/4/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Capricor Therapeutics (NASDAQ:CAPR)CurrentInstitutional OwnershipPercentage21.68%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$3.06MNumber ofInstitutional Sellers(last 12 months)0 Get CAPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Capricor Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CAPR Institutional Buying and Selling by Quarter Ad Investing Daily626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trader has done over the past 8 years—closing 647 trades, with an unbelievable 97% win rate. Now, for the first time, he's breaking his silence and revealing his personal technique for success.Click here to watch our exclusive interview and uncover his personal technique Capricor Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/3/2024 SG Americas Securities LLC8,765$133K0.0%N/A0.027% 8/14/2024Marshall Wace LLP89,314$426K0.0%N/A0.279% 8/9/2024Renaissance Technologies LLC137,500$656K0.0%+158.7%0.430% 8/8/2024Main Street Financial Solutions LLC27,500$131K0.0%+37.5%0.086% 8/1/2024Rhumbline Advisers30,886$147K0.0%N/A0.097% 7/26/2024Bank of New York Mellon Corp79,782$381K0.0%+12.8%0.249% Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/10/2024Vanguard Group Inc.1,365,903$9.27M0.0%+17.2%4.336% 5/1/2024BNP Paribas Financial Markets5,827$40K0.0%N/A0.018% 2/7/2024Jump Financial LLC52,800$258K0.0%N/A0.171% 12/6/2023Citigroup Inc.61,591$211K0.0%N/A0.200% 7/31/2023LPL Financial LLC78,436$375K0.0%N/A0.310% 5/1/2023Virtu Financial LLC16,895$71K0.0%N/A0.067% 11/7/2022Jump Financial LLC22,600$136K0.0%N/A0.093% 10/18/2022 Bailard Inc.33,601$202K0.0%+12.8%0.138% 7/27/2022 Bailard Inc.29,801$104K0.0%N/A0.123% 4/20/2022 Selective Wealth Management Inc.213,494$732K0.3%N/A0.878% 11/16/2021Two Sigma Securities LLC11,511$46K0.0%N/A0.050% 11/15/2021GSA Capital Partners LLP96,632$388K0.0%-14.0%0.420% 11/15/2021HighTower Advisors LLC53,960$215K0.0%+206.6%0.234% 11/9/2021Barclays PLC6,330$25K0.0%+246.1%0.027% 11/9/2021BlackRock Inc.300,201$1.21M0.0%-1.6%1.304% 8/17/2021Oracle Investment Management Inc.1,166,249$5.98M0.8%-41.7%5.098% 8/16/2021State Street Corp71,748$368K0.0%N/A0.314% 8/13/2021Northern Trust Corp104,251$535K0.0%+7.5%0.456% 8/13/2021Geode Capital Management LLC184,990$948K0.0%+7.9%0.809% 8/13/2021Vanguard Group Inc.923,233$4.74M0.0%+1.2%4.035% 8/11/2021Susquehanna Fundamental Investments LLC16,500$85K0.0%-49.1%0.072% 8/5/2021GSA Capital Partners LLP112,364$576K0.1%+684.6%0.491% 5/18/2021Millennium Management LLC22,390$105K0.0%-54.6%0.098% 5/18/2021Oracle Investment Management Inc.1,999,464$9.36M1.4%N/A8.770% 5/12/2021Northern Trust Corp96,941$453K0.0%-29.1%0.425% 5/12/2021M Holdings Securities Inc.20,000$94K0.0%N/A0.088% 5/12/2021Geode Capital Management LLC171,415$802K0.0%+40.7%0.752% 5/10/2021HighTower Advisors LLC12,300$57K0.0%-25.9%0.054% 5/10/2021GSA Capital Partners LLP14,321$67K0.0%-81.9%0.063% 5/7/2021BlackRock Inc.347,103$1.62M0.0%+1.2%1.523% 5/3/2021Trellus Management Company LLC270,000$1.26M0.7%N/A1.184% 2/11/2021Northern Trust Corp136,814$469K0.0%-9.6%0.669% 2/9/2021Bank of New York Mellon Corp89,249$306K0.0%+47.7%0.436% 2/5/2021BlackRock Inc.343,011$1.18M0.0%+0.4%1.677% Elon knows the truth, which is why they want him silenced (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration. Watch this new documentary and you’ll discover what Elon knows,2/4/2021GSA Capital Partners LLP79,091$271K0.0%N/A0.387% 11/17/2020Jane Street Group LLC12,943$68K0.0%-51.1%0.066% 11/13/2020Morgan Stanley44,843$235K0.0%+26.4%0.227% 11/12/2020JPMorgan Chase & Co.5,607$30K0.0%+80,000.0%0.028% 11/6/2020BlackRock Inc.341,523$1.79M0.0%+900.8%1.732% (Data available from 1/1/2016 forward) CAPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CAPR shares? During the previous two years, 12 institutional investors and hedge funds held shares of Capricor Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($9.27M), Renaissance Technologies LLC ($656K), Marshall Wace LLP ($426K), Bank of New York Mellon Corp ($381K), LPL Financial LLC ($375K), Jump Financial LLC ($258K), and Citigroup Inc. ($211K).Learn more on CAPR's institutional investors. What percentage of Capricor Therapeutics stock is owned by institutional investors? 21.68% of Capricor Therapeutics stock is owned by institutional investors. Learn more on CAPR's institutional investor holdings. Which institutional investors have been buying Capricor Therapeutics stock? Of the 12 institutional investors that purchased Capricor Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($200.50K), Marshall Wace LLP ($89.31K), Renaissance Technologies LLC ($84.35K), LPL Financial LLC ($78.44K), Jump Financial LLC ($75.40K), Citigroup Inc. ($61.59K), and Rhumbline Advisers ($30.89K). How much institutional buying is happening at Capricor Therapeutics? Institutional investors have bought a total of 668,503 shares in the last 24 months. This purchase volume represents approximately $3.64M in transactions. Related Companies LPTX Institutional Ownership CLSD Institutional Ownership PRPH Institutional Ownership EYEN Institutional Ownership NRBO Institutional Ownership TNXP Institutional Ownership GLMD Institutional Ownership TGTX Institutional Ownership PBH Institutional Ownership PRGO Institutional Ownership This page (NASDAQ:CAPR) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CAPR Stock Alerts